Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| RYTM Historical Stock Prices |
| Preferred Stock Newsletter |
| RYTM Options Chain |
| Stock Message Boards |
Rhythm Pharmaceuticals (RYTM) has the following price history information. Looking back at RYTM historical stock prices for the last five trading days, on April 11, 2024, RYTM opened at $41.23, traded as high as $42.63 and as low as $41.10, and closed at $42.58. Trading volume was a total of 421.30K shares. On April 12, 2024, RYTM opened at $42.01, traded as high as $42.01 and as low as $39.80, and closed at $40.33. Trading volume was a total of 848.60K shares. On April 15, 2024, RYTM opened at $40.46, traded as high as $41.04 and as low as $39.95, and closed at $40.09. Trading volume was a total of 621.70K shares. On April 16, 2024, RYTM opened at $39.59, traded as high as $40.13 and as low as $38.51, and closed at $38.52. Trading volume was a total of 422.10K shares. On April 17, 2024, RYTM opened at $39.10, traded as high as $39.10 and as low as $38.25, and closed at $38.45. Trading volume was a total of 599.50K shares.
RYTM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Rhythm Pharmaceuticals shares, starting with a $10,000 purchase of RYTM, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 10/10/2017 | |
| End date: | 04/17/2024 | |
| Start price/share: | $26.01 | |
| End price/share: | $38.45 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 47.83% | |
| Average Annual Total Return: | 6.18% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $14,787.14 | |
| Years: | 6.52 | |
 | |||||
| RYTM Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 04/11/2024 | $41.23 | $42.63 | $41.10 | $42.58 | 421.30K |
| 04/12/2024 | $42.01 | $42.01 | $39.80 | $40.33 | 848.60K |
| 04/15/2024 | $40.46 | $41.04 | $39.95 | $40.09 | 621.70K |
| 04/16/2024 | $39.59 | $40.13 | $38.51 | $38.52 | 422.10K |
| 04/17/2024 | $39.10 | $39.10 | $38.25 | $38.45 | 599.50K |
|
| About Rhythm Pharmaceuticals |
| Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company to transform the lives of patients and their families living with rare diseases. Co. is focused on developing IMCIVREE® (setmelanotide), as a medicine designed to treat hyperphagia and severe obesity caused by melanocortin-4 receptor pathway diseases. IMCIVREE is approved by the U.S. Food and Drug Administration for chronic weight management in adult and pediatric patients six years of age and older with monogenic or syndromic obesity due to: proopiomelanocortin, proprotein convertase subtilisin/kexin type 1 or leptin receptor deficiency; or Bardet-Biedl syndrome. |
| RYTM Historical Closing Prices | |
| Date | Close |
| 04/11/2024 | $42.58 |
| 04/12/2024 | $40.33 |
| 04/15/2024 | $40.09 |
| 04/16/2024 | $38.52 |
| 04/17/2024 | $38.45 |
| Healthcare Historical Prices |
| RYTM is categorized under the Healthcare sector; below are some other companies in the same sector:
SAGE Historical Stock Prices Also explore: RYTM shares outstanding history
|
Free RYTM Email Alerts:
RYTM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.